1.
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
by Sun, Lulu
Nature medicine, 2018-12, Vol.24 (12), p.1919-1929

2.
Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
by Camporez, João Paulo G
Endocrinology (Philadelphia), 2013-09, Vol.154 (9), p.3099-3109

3.
Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey
by Ziegler, Dan
Diabetologia, 2015-02-28, Vol.58 (5), p.1118-1128

4.
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profi...
by Bianchi, Cristina
The journal of clinical endocrinology and metabolism, 2013-05, Vol.98 (5), p.2100-2105

5.
The Incidence of Glucose Disorders Related to Cystic Fibrosis Could Be Higher with Current Criteria (Re: Carbohydrate Metabolism Changes in Cystic Fibrosis. J Pediatr Endocrinol Me...
by Arroyo Hernández, Mireia
Journal of Pediatric Endocrinology & Metabolism, 2008-06-01, Vol.21 (6), p.605-605

6.
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study
by Soriguer, F
Diabetologia, 2011-10-11, Vol.55 (1), p.88-93

7.
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
by Fleseriu, Maria
The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.2039-2049

8.
Testosterone to Dihydrotestosterone Ratio as a New Biomarker for an Adverse Metabolic Phenotype in the Polycystic Ovary Syndrome
by Münzker, J
The journal of clinical endocrinology and metabolism, 2015-02, Vol.100 (2), p.653-660

9.
Increased Arterial Stiffness in Subjects with Impaired Glucose Tolerance and Newly Diagnosed Diabetes But Not Isolated Impaired Fasting Glucose
by Li, Chung-Hao
The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.E658-E662

10.
Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance
by Deleskog, A
Diabetologia, 2012-03-17, Vol.55 (6), p.1668-1678

11.
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia
by Fiorentino, Teresa Vanessa
The journal of clinical endocrinology and metabolism, 2017-11, Vol.102 (11), p.3979-3989

12.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094

13.
Ethnic Differences in Insulin Sensitivity, β-Cell Function, and Hepatic Extraction Between Japanese and Caucasians: A Minimal Model Analysis
by Møller, Jonas B
The journal of clinical endocrinology and metabolism, 2014-11, Vol.99 (11), p.4273-4280

14.
Circulating Betatrophin Concentrations Are Decreased in Human Obesity and Type 2 Diabetes
by Gómez-Ambrosi, Javier
The journal of clinical endocrinology and metabolism, 2014-10, Vol.99 (10), p.E2004-E2009

15.
Effects of Monounsaturated Fatty Acids on Glycaemic Control in Patients with Abnormal Glucose Metabolism: A Systematic Review and Meta-Analysis
by Schwingshackl, L
Annals of nutrition and metabolism, 2011-01-01, Vol.58 (4), p.290-296

16.
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
by Manell, Hannes
The journal of clinical endocrinology and metabolism, 2016-03, Vol.101 (3), p.1181-1189

17.
Physical Activity and Improvement of Glycemia in Prediabetes by Different Diagnostic Criteria
by Færch, Kristine
The journal of clinical endocrinology and metabolism, 2017-10-01, Vol.102 (10), p.3712-3721

18.
Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance
by Best, Conor
The journal of clinical endocrinology and metabolism, 2015-07, Vol.100 (7), p.2621-2629

19.
Inactivating hepatic follistatin alleviates hyperglycemia
by Tao, Rongya
Nature medicine, 2018-07, Vol.24 (7), p.1058-1069

20.
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic...
by Wild, Robert A
The journal of clinical endocrinology and metabolism, 2010-05, Vol.95 (5), p.2038-2049
